US Patent 8288338 Exendin and exendin agonists for eating disorders
Patent 8288338 was granted and assigned to Amylin Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 24 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08288338 Exendin and exendin agonists for eating disorders US Patent 8288338 Exendin and exendin agonists for eating disorders
Infobox
Patent Number
0828833800
Patent Number
828833800
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082883380
Date of Patent
October 16, 2012
0Patent Application Number
127661950
Date Filed
April 23, 2010
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082883380
Date of Patent
October 16, 2012
0Patent Application Number
127661950
Date Filed
April 23, 2010
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08288338 Exendin and exendin agonists for eating disorders
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08288338
Date of patent
October 16, 2012
Patent application number
12766195
Date Filed
April 23, 2010
Patent primary examiner
Find more entities like US Patent 8288338 Exendin and exendin agonists for eating disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
